Ori Warshavsky
Chief Operating Officer - USMr. Ori Warshavsky is the Chief Operating Officer - US at PolyPid Ltd. since January 2022 and served as its Vice President of Marketing since 2020. He has international experience in the pharmaceuticals industry with experience ranging from corporate strategy and business development to marketing and market access. Prior to joining Polypid, he spent 10 years at Teva Pharmaceuticals with his last role being Senior Director of Oncology Marketing where he led the launch of several oncology products. Earlier in his career he served as the Head of Market Access for Teva in Canada and as Chief of Staff to the CEO of Teva’s global generics business. He started his career as a biotech engineer both in Israel and the US. He holds a B.Sc. degree in Biotechnology Engineering from the Ben-Gurion University and an MBA from Duke University’s Fuqua School of Business.
Positions
- Company NamePolyPid Ltd.Stock CodePYPDPositionChief Operating Officer - USColleagues
- DCDikla Czaczkes AkselbradCEO & Director
- BEBrooke Elizabeth StoryIndependent Non-Employee Chairman of the Board
- JMJonny MissulawinChief Financial Officer
- DHDalit HazanDeputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs
- MRMaria RubinExecutive Vice President of Operations
- IKItzhak KrinskyIndependent Non-Employee Director
- NDNir DrorIndependent Non-Employee Director
- YBYechezkel BarenholzIndependent Non-Employee Director
